We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$478B
AUM Growth
+$50B
Cap. Flow
+$13.3B
Cap. Flow %
2.79%
Top 10 Hldgs %
18.61%
Holding
4,322
New
132
Increased
3,091
Reduced
523
Closed
113

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$848M
2
BMY icon
Bristol-Myers Squibb
BMY
+$631M
3
TFC icon
Truist Financial
TFC
+$445M
4
AMZN icon
Amazon
AMZN
+$334M
5
NOW icon
ServiceNow
NOW
+$251M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Financials 15.45%
3 Healthcare 13.87%
4 Consumer Discretionary 9.9%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMNB icon
2351
Farmers National Banc Corp
FMNB
$968M
$5.66M ﹤0.01%
346,698
+18,533
+6% +$283K
CCRN
2352
DELISTED
Cross Country Healthcare
CCRN
$5.65M ﹤0.01%
485,909
+7,526
+2% +$85K
CPRX
2353
DELISTED
Catalyst Pharmaceutical
CPRX
$5.64M ﹤0.01%
1,504,321
-19,083
-1% -$89.2K
BPY
2354
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$5.62M ﹤0.01%
307,797
+1,284
+0.4% +$24.3K
HFFG icon
2355
HF Foods Group
HFFG
$95.9M
$5.62M ﹤0.01%
288,146
+221,878
+335% +$4.41M
OLP
2356
One Liberty Properties
OLP
$532M
$5.61M ﹤0.01%
206,474
+5,356
+3% +$147K
CRC
2357
DELISTED
California Resources Corporation
CRC
$5.61M ﹤0.01%
621,683
-17,745
-3% -$144K
SPPI
2358
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$5.61M ﹤0.01%
1,541,427
+70,544
+5% +$570K
GTS
2359
DELISTED
Triple-S Management Corporation
GTS
$5.59M ﹤0.01%
302,443
+11,060
+4% +$189K
NVS icon
2360
Novartis
NVS
$290B
$5.58M ﹤0.01%
58,940
-1,011
-2% -$90.7K
DMRC icon
2361
Digimarc Corp
DMRC
$155M
$5.57M ﹤0.01%
166,075
+4,645
+3% +$167K
MEET
2362
DELISTED
The Meet Group, Inc. Common Stock
MEET
$5.54M ﹤0.01%
1,105,529
-166,103
-13% -$781K
CSV icon
2363
Carriage Services
CSV
$556M
$5.54M ﹤0.01%
216,291
+8,142
+4% +$197K
BZH icon
2364
Beazer Homes USA
BZH
$874M
$5.51M ﹤0.01%
390,075
+16,227
+4% +$246K
IMAX icon
2365
IMAX
IMAX
$2.89B
$5.51M ﹤0.01%
269,572
+15,129
+6% +$323K
CRH icon
2366
CRH
CRH
$65.6B
$5.5M ﹤0.01%
136,435
+82,429
+153% +$3.05M
OFLX icon
2367
Omega Flex
OFLX
$298M
$5.5M ﹤0.01%
51,221
+2,246
+5% +$219K
JCAP
2368
DELISTED
Jernigan Capital, Inc.
JCAP
$5.48M ﹤0.01%
286,193
+28,614
+11% +$526K
CTMX icon
2369
CytomX Therapeutics
CTMX
$736M
$5.45M ﹤0.01%
656,257
+39,211
+6% +$265K
MLR icon
2370
Miller Industries
MLR
$635M
$5.45M ﹤0.01%
146,841
+5,633
+4% +$198K
ODT
2371
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$5.45M ﹤0.01%
167,986
+4,342
+3% +$135K
TUP
2372
DELISTED
Tupperware Brands Corporation
TUP
$5.44M ﹤0.01%
634,138
-87,579
-12% -$955K
AMRN
2373
Amarin Corp
AMRN
$299M
$5.42M ﹤0.01%
12,649
+164
+1% +$62.3K
IIIN icon
2374
Insteel Industries
IIIN
$632M
$5.42M ﹤0.01%
252,346
+8,694
+4% +$184K
WNS
2375
DELISTED
WNS Holdings
WNS
$5.41M ﹤0.01%
81,827
-3,886
-5% -$242K

Similar funds

Geode Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
  • Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
  • Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
  • Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
  • Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
  • Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
  • Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.

Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.